REGISTERED AND RENEWED
on 20 Apr 2023
Last Applicant/ Owned by
3031 US Highway 130
Monmouth Junction
NJ
08852
Serial Number
85332659 filed on 27th May 2011
Registration Number
4392798 registered on 27th Aug 2013
Correspondent Address
Cathy A. Kodroff
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
QUILLIVANT
Oral liquid suspension pharmaceutical preparations for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder; methylphenidate hydrochloride in oral suspension liquid form for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder
Classification Information
Class [005]
Pharmaceutical Products
Oral liquid suspension pharmaceutical preparations for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder; methylphenidate hydrochloride in oral suspension liquid form for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder
First Use Date in General
14th Jan 2013
First Use Date in Commerce
14th Jan 2013
Mark Details
Serial Number
No 85332659
Mark Type
No Service/Collective Mark
Attorney Docket Number
No TRIS-QUILLIV
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 20th Apr 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| 20th Apr 2023 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| 20th Apr 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 20th Apr 2023 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| 07th Oct 2022 | TEAS SECTION 8 & 9 RECEIVED |
| 27th Aug 2022 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 26th Aug 2019 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 26th Aug 2019 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 26th Aug 2019 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 16th Jul 2019 | TEAS SECTION 8 & 15 RECEIVED |